Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway
Abstract Purpose Leucine-rich repeat-containing 15 (LRRC15) is a transmembrane protein that is highly expressed in the synovium of patients with rheumatoid arthritis (RA). Brevilin A (BrA), an active compound isolated from Centipeda minima, exerts potent anti-inflammatory effects. However, the anti-...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-08-01
|
| coleção: | Arthritis Research & Therapy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s13075-025-03629-1 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|